Platelet Aggregation in Stable Angina Patients Treated With Aspirin and Clopidogrel is Modulated by 6.3/6.7 Kb Polymorphism of the Platelet Alpha2a-Adrenergic Receptor

被引：0
|
作者：
Peace, Aaron J. [1 ]
Mangiacapra, Fabio [1 ]
Bailleul, Els [1 ]
Delrue, Leen [1 ]
Conte, Micaela [1 ]
Puymirat, Etienne [1 ]
Fraeyman, Annelies [1 ]
Meeus, Peter [1 ]
Bartunek, Jozef [1 ]
Barbato, Emanuele [1 ]
机构：
[1] OLVZ, Aalst, Belgium
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Antiplatelet drugs; Gene mutations;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18363
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients
    Nardin, Matteo
    Verdoia, Monica
    Pergolini, Patrizia
    Rolla, Roberta
    Barbieri, Lucia
    Marino, Paolo
    Bellomo, Giorgio
    Kedhi, Elvin
    Suryapranata, Harry
    Carriero, Alessandro
    De Luca, Giuseppe
    PHARMACOLOGICAL RESEARCH, 2018, 129 : 27 - 33
  • [42] IMPACT OF ADENOSINE A2A RECEPTOR POLYMORPHISM RS5751876 ON PLATELET REACTIVITY IN TICAGRELOR TREATED PATIENTS
    Verdoia, Monica
    Nardin, Matteo
    Barbieri, Lucia
    Rolla, Roberta
    Galasso, Gennaro
    Marino, Paolo
    Bellomo, Giorgio
    De Luca, Giuseppe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 99 - 99
  • [43] Platelet alpha-2 adrenergic receptor has a role in thienopyridine-resistance of stable coronary artery disease patients on conventional dual antiplatelet therapy
    Beres, B. J.
    Toth-Zsamboki, E.
    Vargova, K.
    Preda, I
    Kiss, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 584 - 585
  • [44] Inhibition of platelet aggregation with prasugrel (CS-747, LY640315), a novel thanopyridine P2Y12 receptor antagonist, compared with clopidogrel in aspirin-treated patients with atherosclerotic vascular disease
    Wallentin, L
    Jernberg, T
    Leese, PT
    Nilsson, LG
    Payne, CD
    Darstein, C
    Brandt, JT
    Jakubowski, JA
    Winters, KJ
    Siegbahn, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 416A - 416A
  • [45] Detection of clopidogrel resistance: comparison of a new, P2Y12 receptor specific platelet aggregation test and other laboratory methods in patients on clopidogrel monotherapy
    Bagoly, Z.
    Sarkady, F.
    Magyar, T.
    Pongracz, E.
    Kappelmayer, J.
    Csiba, L.
    Muszbek, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 48 - 48
  • [46] DESENSITIZATION OF EPINEPHRINE-INITIATED PLATELET-AGGREGATION DOES NOT ALTER BINDING TO THE ALPHA-2-ADRENERGIC RECEPTOR OR RECEPTOR COUPLING TO ADENYLATE-CYCLASE
    MOTULSKY, HJ
    SHATTIL, SJ
    FERRY, N
    ROZANSKY, D
    INSEL, PA
    MOLECULAR PHARMACOLOGY, 1986, 29 (01) : 1 - 6
  • [47] Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: The PLavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial
    Serebruany, VL
    Malinin, AI
    Jerome, SD
    Lowry, DR
    Morgan, AW
    Sane, DC
    Tanguay, JF
    Steinhubl, SR
    O'Connor, DM
    AMERICAN HEART JOURNAL, 2003, 146 (04) : 713 - 720
  • [48] Prasugrel (CS-747) achieves significantly higher inhibition of platelet aggregation and a lower rate of nonresponders compared with clopidogrel in aspirin-treated patients with atherosclerotic vascular disease
    Winters, KJ
    Jernberg, T
    Leese, PT
    Nilsson, LG
    Payne, CD
    Darstein, C
    Brandt, JT
    Jakubowski, JA
    Siegbahn, A
    Wallentin, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 154H - 154H
  • [49] Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease
    Angiolillo, DJ
    Fernandez-Ortiz, A
    Bernardo, E
    Ramírez, C
    Cavallari, U
    Trabetti, E
    Sabaté, M
    Jimenez-Quevedo, P
    Hernández, R
    Moreno, R
    Escaned, J
    Alfonso, F
    Bañuelos, C
    Costa, MA
    Bass, TA
    Pignatti, PF
    Macaya, C
    THROMBOSIS RESEARCH, 2005, 116 (06) : 491 - 497
  • [50] CYTOCHROME P450 2C19*17 POLYMORPHISM OFFSETS THE NEGATIVE EFFECT OF 2C19*2 POLYMORPHISM ON PLATELET REACTIVITY IN PATIENTS TREATED WITH CLOPIDOGREL
    Dery, U.
    Tourlgny, E.
    Roy, M.
    Nadeau, P. L.
    Giguere, M. E.
    Rodes-Cabau, J.
    Larose, E.
    Rinfret, S.
    Gleeton, O.
    Proulx, G.
    Barbeau, G.
    Noel, B.
    Roy, L.
    De Larochelliere, R.
    Nguyen, C. M.
    Bosse, Y.
    Tricoci, P.
    Becker, R. C.
    Bertrand, O. F.
    Dery, J. P.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S183 - S184
12345